Global Markets for Treatments for Syndromes of Dementia and Movement Disorders

Sep 2012| PHM117A| BCC Publishing

Report Highlights

The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

SCOPE OF THE STUDY

The scope of this study encompasses the neurodegenerative disorders in the pharmaceutical and biotechnology markets.  BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share.  Technological issues include the latest trends and developments.  The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand and Mexico.

Frequently Asked Questions (FAQs)

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Treatments for Syndromes of Dementia and Movement Disorders228Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: OVERVIEW10Free
Chapter- 4: REGULATORY ASPECTS5Free
Chapter- 5: NEW DEVELOPMENTS19Free
Chapter- 6: GLOBAL MARKETS13Free
Chapter- 7: MARKET FOR DRUG PRODUCTS USED TO TREAT PROGRESSIVE DEMENTIA32Free
Chapter- 8: MARKET FOR DRUGS TO TREAT PROGRESSIVE DEMENTIA WITH OTHER NEUROLOGICAL ABNORMALITIES24Free
Chapter- 9: MARKET FOR MOVEMENT DISORDER SYNDROMES35Free
Chapter- 10: PATENT ANALYSIS20Free
Chapter- 11: CURRENT SITUATION7Free
Chapter- 12: C. CRAMER & CO. GMBH55Free
Chapter- 13: APPENDIX I: ABBREVIATIONS3Free
Global Markets for Treatments for Syndromes of Dementia and Movement Disorders

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS